bg
M

Moleculin Biotech (MBRX)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Moleculin Biotech (MBRX)

Moleculin Biotech, Inc. is a clinical-stage pharmaceutical company. The Company is focused on the treatment of cancers. Its clinical stage drug candidates include Annamycin, WP1066, WP1220, WP1732, WP1122 and WP1234. Annamycin is intended for the tre... Read more

  • USD4.80
  • USD5.69
  • USD4.75
  • USD24.75
  • -40.00%
  • 4.00
  • 74.15k
  • 13M
  • 4.34
  • -61.60%

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.